1. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation;Brittberg;N Engl J Med,1994
2. EMA. Reflection paper on in-vitro cultured chondrocyte containing products for cartilage repair of the knee (EMA/CAT/CPWP/568181/2009). Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2010/05/ WC500090887.pdf. Accessed 03 December 2012.
3. FDA. Guidance for industry: preparation of IDEs and INDs for products intended to repair or replace knee cartilage. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ UCM288011.pdf. Accessed 03 December 2012.
4. FDA regulatory pathways for knee cartilage repair products;Levine;Sports Med Arthrosc Rev,2008
5. Guidelines for the design and conduct of clinical studies in knee articular cartilage repair: International Cartilage Repair Society recommendations based on current scientific evidence and standards of clinical care;Mithoefer;Cartilage,2011